Multiple BCG vaccinations for the prevention of COVID-19 and other infectious diseases in type 1 diabetes

There is a need for safe and effective platform vaccines to protect against coronavirus disease 2019 (COVID-19) and other infectious diseases. In this randomized, double-blinded, placebo-controlled phase 2/3 trial, we evaluate the safety and efficacy of a multi-dose Bacillus Calmette-Guérin (BCG) va...

Descripción completa

Detalles Bibliográficos
Autores principales: Faustman, Denise L., Lee, Amanda, Hostetter, Emma R., Aristarkhova, Anna, Ng, Nathan C., Shpilsky, Gabriella F., Tran, Lisa, Wolfe, Grace, Takahashi, Hiroyuki, Dias, Hans F., Braley, Joan, Zheng, Hui, Schoenfeld, David A., Kühtreiber, Willem M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376308/
https://www.ncbi.nlm.nih.gov/pubmed/36027906
http://dx.doi.org/10.1016/j.xcrm.2022.100728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376308/
https://www.ncbi.nlm.nih.gov/pubmed/36027906
http://dx.doi.org/10.1016/j.xcrm.2022.100728

Ejemplares similares